Arkolith/Insider Trading/TELO/Form 4

McNulty Brian Patrick

10% OwnerTelomir Pharmaceuticals, Inc. (TELO) · full profile →Form 4 · filed Feb 15, 2024
Net Buying
Open-Market Buys
$966K
Open-Market Sells
$0
Net Open-Market Flow
$966K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 13, 2024Buy(P)49K$7.00$343K5.5M
Feb 13, 2024Buy(P)40K$7.00$280K1.4M
Feb 13, 2024Buy(P)49K$7.00$343K1.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000897069-24-000395) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML